Venus Pharmaceuticals International is categorized under in Hauppauge, NY and active since 2002.
Venus Pharmaceuticals International was established in 2002, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Sunny Singh, Owner at the company’s single location by writing to 65 Kennedy Drive # A, Hauppauge, New York NY 11788 or by phoning (631) 249-4140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Venus Pharmaceuticals International |
| Contact Person: | Sunny Singh, Owner |
| Address: | 65 Kennedy Drive # A, Hauppauge, New York 11788 |
| Phone Number: | (631) 249-4140 |
| Website Address: | venuspharmaceuticals.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 3254120 |
| Share This Business: |
Venus Pharmaceuticals International was started in 2002 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Sunny Singh, Owner for inquiries that concern Venus Pharmaceuticals International by calling the company number (631) 249-4140, as your correspondence is most welcome. Additionally, the physical location of the single location of Venus Pharmaceuticals International can be found at the coordinates 40.8118,-73.2411 as well as the street address 65 Kennedy Drive # A in Hauppauge, New York 11788.
For its online presence, you may visit Venus Pharmaceuticals International’s website at venuspharmaceuticals.com and engage with its social media outlets through on Twitter and on Facebook.